Microba Life Sciences Share Price and Company Fundamentals
Last traded: Last Friday at 6:10 AM
Microba Life Sciences Limited operates as a gut microbiome analysis company in Australia. It offers Insight, a test for the metagenomic analysis of the gut microbiome; and bespoke health management solutions for partners and practitioners to improve patient care. The company was incorporated in 2017 and is based in Brisbane, Australia.
Key Metrics
PE ratio
-
PB ratio
-
Dividend yield
0.00%
Beta
-
Market cap
-
Enterprise value
-
Company profile
| Primary activities | Microba is a commercial stage company with leading technology for measuring the human gut microbiome. |
|---|---|
| Industry / Sector | Diagnostics & Research / Healthcare |
| Website | https://www.microba.com |
| Mailing address | 388 Queen Street Level 12 Brisbane QLD 4000 Australia |
| Phone / Fax | 1300 974 621 / |
| Share registry | AUTOMIC REGISTRY SERVICES |
Dividends
More: Microba Life Sciences Dividend history, yield and payout ratio
Dividend yield
0.00%
Dividend amount
$0.00
Payout ratio
Microba Life Sciences paid $0.00 dividend and the ex-dividend date was .The dividend payout ratio is . The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.
MAP's forward dividend amount is $ and the forward dividend yield is . A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.
Company Executives
As of Jul 2022, following are the company executives and directors listed on Microba Life Sciences.
| Name | Title | Age | Total Pay |
|---|
Profitability and management effectiveness
Profit margin
-268.28%
Operating margin
-308.19%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Microba Life Sciences is and its enterprise value is .
Companies similar to Microba Life Sciences (MAP)
- Ansell (ANN)
- Cochlear (COH)
- Fisher & Paykel Healthcare Corporation (FPH)
- Estia Health (EHE)
- Healius (HLS)
- Nanosonics (NAN)
- Pro Medicus (PME)
- Resmed Inc (RMD)
- Ramsay Health Care (RHC)
- Polynovo (PNV)
- Sonic Healthcare (SHL)
Microba Life Sciences (ASX:MAP) Frequently Asked Questions
1. What is Microba Life Sciences's Stock Symbol?
Microba Life Sciences trades on ASX under the ticker symbol "MAP".
2. What is Microba Life Sciences's stock price today?
One share of MAP stock can currently be purchased for approximately $0.2.
3. How can I contact Microba Life Sciences?
Microba Life Sciences's mailing address is 388 Queen Street Level 12 Brisbane QLD 4000 Australia. The company can be reached via phone at 1300 974 621.
4. What is Microba Life Sciences's official website?
The official website of Microba Life Sciences is https://www.microba.com.
5. Which share registry manages Microba Life Sciences's stock?
Microba Life Sciences's stock is managed by AUTOMIC REGISTRY SERVICES.